ID   TK-1B
AC   CVCL_B331
DR   Cosmic; 787481
DR   Cosmic; 975304
DR   DSMZ; ACC-946
DR   Wikidata; Q54972527
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3457771;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3457771); ~48-72 hours (DSMZ=ACC-946).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-946
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 15,21
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B326 ! TK-1 [Human myeloid leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
RX   PubMed=3457771; DOI=10.1002/ijc.2910370518;
RA   Ohno, Hitoshi
RA   Doi, Shoichi
RA   Fukuhara, Shiro
RA   Yamasowa, Michihiko
RA   Kannagi, Mari
RA   Ishikura, Hiroto
RA   Nishikori, Masaru
RA   Uchino, Haruto
RT   "Establishment of a new myeloid leukemia cell line (TK-1), and
RT   isolation of cells having a translocation involving a band 17q23.";
RL   Int. J. Cancer 37:761-767(1986).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//